FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| ANCHOR THERAPEUTICS | ANCHOR THERAPEUTICS, INC. | 67 Rogers Street Cambridge MA 02142 | Pharmaceutical agents, namely, peptides, for the prevention, relief or treatment of human diseases, namely, metabolic disorders, cancer, inflammation, and disorders of the organs including the nervous system, cardiovascular system, gastrointestinal system, endocrinological system, pulmonary system, dermatologic system, immunologic system, special senses, namely, the olfactory system and the sense of taste, bones and joints; Synthetic peptides preventing, relieving or treating physiological conditions and disorders, namely, metabolic disorders, cancer, inflammation, and disorders of the organs including the nervous system, cardiovascular system, gastrointestinal system, endocrinological system, pulmonary system, dermatologic system, immunologic system, special senses, namely, the olfactory system and the sense of taste, bones and joints;THERAPEUTICS; |
| ANCHOR THERAPEUTICS | Ascent Therapeutics, Inc. | 67 Rogers Street Cambridge MA 02142 | Pharmaceutical agents, namely, peptides, for the prevention, relief or treatment of human diseases, namely, metabolic disorders, cancer, inflammation, and disorders of the organs including the nervous system, cardiovascular system, gastrointestinal system, endocrinological system, pulmonary system, dermatologic system, immunologic system, special senses, namely, the olfactory system and the sense of taste, bones and joints; Synthetic peptides preventing, relieving or treating physiological conditions and disorders, namely, metabolic disorders, cancer, inflammation, and disorders of the organs including the nervous system, cardiovascular system, gastrointestinal system, endocrinological system, pulmonary system, dermatologic system, immunologic system, special senses, namely, the olfactory system and the sense of taste, bones and joints;THERAPEUTICS; |
| CYLLENE | Cellarity, Inc. | 101 South Street, Suite 600 Somerville MA 02143 | Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; bioinformatic services, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; |
| GEODESIC | Cellarity, Inc. | 101 South Street, Suite 600 Somerville MA 02143 | Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; bioinformatic services, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations: Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; Providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; Providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; Scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; Providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; |
| IMCOR | Photogen Technologies, Inc. | 140 Union Square Drive New Hope PA 18938 | Pharmaceutical agents, namely contrast agents for use with imaging technologies; |
| IMCOR | Photogen Technologies, Inc. | 140 Union Square Drive New Hope PA 18938 | Pharmaceutical agents, namely contrast agents for use with imaging technologies;The stippling in the drawing is for shading purposes only.; |
| KYTOSIA | Cellarity, Inc. | 101 South Street, Suite 600 Somerville MA 02143 | Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; bioinformatic services, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations: providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; |
| PERSONARX | R80 | 8120 Woodmont Ave, Suite 180 Bethesda MD 20814 | Pharmaceutical agents, vitamin and mineral preparations affecting metabolism;Pharmaceutical compounding services; |
| REJUVEINIX | Reven Holdings, Inc. | 600 Corporate Circle, Suite D Golden CO 80401 | Pharmaceutical agents, formulations and drug products for the treatment of inflammatory disorders, systemic inflammation, sepsis, multi-organ dysfunction syndrome, cytokine storm, cytokine release syndrome, central and peripheral nervous system disorders, metabolic disorders, cardiovascular diseases, cancer, infectious diseases, viral illnesses; |
| REWRITING THE RULES OF DRUG CREATION | Cellarity, Inc. | 101 South Street, Suite 600 Somerville MA 02143 | Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders, and other diseases and disorders; bioinformatic services, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations: providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; |
Where the owner name is not linked, that owner no longer owns the brand |